DrugPatentWatch Database Preview
Ani Pharms Inc Company Profile
What is the competitive landscape for ANI PHARMS INC, and when can generic versions of ANI PHARMS INC drugs launch?
ANI PHARMS INC has one hundred and fifty-five approved drugs.
There is one US patent protecting ANI PHARMS INC drugs.
There are fourteen patent family members on ANI PHARMS INC drugs in eleven countries and thirty-one supplementary protection certificates in nine countries.
Summary for Ani Pharms Inc
| International Patents: | 14 |
| US Patents: | 1 |
| Tradenames: | 90 |
| Ingredients: | 86 |
| NDAs: | 155 |
Drugs and US Patents for Ani Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ani Pharms Inc | SULFAMETHOXAZOLE AND TRIMETHOPRIM | sulfamethoxazole; trimethoprim | SUSPENSION;ORAL | 077612-001 | Nov 13, 2006 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Ani Pharms Inc | NEFAZODONE HYDROCHLORIDE | nefazodone hydrochloride | TABLET;ORAL | 076072-004 | Sep 16, 2003 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Ani Pharms Inc | MEXILETINE HYDROCHLORIDE | mexiletine hydrochloride | CAPSULE;ORAL | 074450-001 | May 16, 1996 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Ani Pharms Inc | PRAZOSIN HYDROCHLORIDE | prazosin hydrochloride | CAPSULE;ORAL | 072577-002 | May 16, 1989 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Ani Pharms Inc | CEFADROXIL | cefadroxil/cefadroxil hemihydrate | FOR SUSPENSION;ORAL | 062698-001 | Mar 1, 1989 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Ani Pharms Inc | CLARITHROMYCIN | clarithromycin | TABLET, EXTENDED RELEASE;ORAL | 065250-001 | Aug 25, 2005 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Ani Pharms Inc | INDAPAMIDE | indapamide | TABLET;ORAL | 074299-002 | Apr 29, 1996 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Ani Pharms Inc
Paragraph IV (Patent) Challenges for ANI PHARMS INC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 16 mg/12.5 mg and 32 mg/12.5 mg | ➤ Subscribe | 2008-06-25 |
| ➤ Subscribe | Tablets | 4 mg, 8 mg, 16 mg and 32 mg | ➤ Subscribe | 2006-12-22 |
| ➤ Subscribe | Tablets | 32 mg/25 mg | ➤ Subscribe | 2009-03-06 |
International Patents for Ani Pharms Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2462637 | ➤ Sign Up |
| South Korea | 101090719 | ➤ Sign Up |
| Austria | 442134 | ➤ Sign Up |
| Norway | 335070 | ➤ Sign Up |
| Mexico | PA04003234 | ➤ Sign Up |
| Spain | 2333306 | ➤ Sign Up |
| Germany | 60233668 | ➤ Sign Up |
| Country | Patent Number | Estimated Expiration |
Supplementary Protection Certificates for Ani Pharms Inc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0459136 | 8/1998 | Austria | ➤ Sign Up | PRODUCT NAME: CANDESARTAN CILEXETIL ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; NAT. REGISTRATION NO/DATE: 1-22232, 1-22233, 1-22235, 1-22236 19971119; FIRST REGISTRATION: GB PL 15661/0001 - PL 15661/0004 19970429 |
| 0459136 | 98C0016 | Belgium | ➤ Sign Up | PRODUCT NAME: CANDESARTAN CILEXETIL; NAT. REGISTRATION NO/DATE: 212 IS 236 F3 19980119; FIRST REGISTRATION: GB PL 15661/0001 19970429 |
| 0473687 | SPC/GB98/030 | United Kingdom | ➤ Sign Up | PRODUCT NAME: FOSPHENYTOIN SODIUM (3-HYDROXYMETHYL)-5,5-DIPHENYLHYDANTOIN DISODIUM PHOSPHATE ESTER); REGISTERED: UK 0019/0157 19980204 |
| 0459136 | C970044 | Netherlands | ➤ Sign Up | PRODUCT NAME: CANDESARTAN, DESGENST IN DE VORM VAN EEN FARMACEUTISCH AAN- VAARDBAAR ZOUT OF VAN DE 1-(CYCLOHEXYLOXYCARBONYLOXY) ETHYLESTE R, IN HET BIJZONDER CILEXETILI CANDESARTANAS, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; NAT. REGISTRATION NO/DATE: RVG 21703 - RVG 21706 19971013; FIRST REGISTRATION: GB PL 15661/0001 - PL 15661/0004 19970429 |
| 0454511 | 99C0009 | Belgium | ➤ Sign Up | PRODUCT NAME: IRBESARTAN / HYDROCHLOROTHIAZIDE; REGISTRATION NO/DATE: EU/1/98/086/001 19981015 |
| 0196132 | 94C0008 | Belgium | ➤ Sign Up | PRODUCT NAME: RISPERIDONE; NAT REG.: 2 S 414 F 3 19940527; FIRST REG.: GB 0242/0186 19921208 |
| 0503785 | CA 2011 00026 | Denmark | ➤ Sign Up | PRODUCT NAME: A COMBINATION OF OLMESARTAN MEDOXOMIL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, AND AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE; NAT. REG. NO/DATE: 46260-46269 (DK) 20110323; FIRST REG. NO/DATE: DE 79810.00.00 20101216 |
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
